Refractory Shock Secondary to Denosumab-induced Severe Hypocalcaemia

Denosumab is one of the most commonly used antiresorptive drugs for osteoporosis treatment and the prevention of skeletal-related events in cancer patients. The purpose of this case report is to highlight potentially life-threatening severe hypocalcaemia as a side effect of denosumab complicated by...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshak, Nouran, Abdelnabi, Mahmoud, Benjanuwattra, Juthipong, Ismail, Amr, Leelaviwat, Natnicha, Elharabi, Zeyad, Culberson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829022/
https://www.ncbi.nlm.nih.gov/pubmed/36632534
http://dx.doi.org/10.12890/2022_003706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829022/
https://www.ncbi.nlm.nih.gov/pubmed/36632534
http://dx.doi.org/10.12890/2022_003706

Ejemplares similares